The gene expression of adrenomedullin, calcitonin-receptor-like receptor and receptor activity modifying proteins (RAMPs) in CCl4-induced rat liver cirrhosis

Regulatory Peptides

Volumn 135, Issue 1-2, 2006, Pages 69-77

  Hwang, Isabel Shui Shan ^a   Tang, Fai ^a   Leung, Pauline P ^a   Li, Yuk Yin ^a   Fan, Sheung Tat ^a   Luk, John Moon Ching ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adrenomedullin; Calcitonin receptor; Liver cirrhosis; RAMP

Indexed keywords

ADRENOMEDULLIN; CALCITONIN RECEPTOR LIKE RECEPTOR; CARBON TETRACHLORIDE; MESSENGER RNA; OLIVE OIL; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; BODY WEIGHT; CONTROLLED STUDY; FIBROSIS; GENE EXPRESSION; LIVER CIRRHOSIS; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; VASODILATATION;

ADRENOMEDULLIN; ANIMALS; CALCITONIN RECEPTOR-LIKE PROTEIN; CARBON TETRACHLORIDE; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MEMBRANE PROTEINS; NITRATES; NITRITES; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; RECEPTOR ACTIVITY-MODIFYING PROTEINS; RECEPTORS, CALCITONIN; RENIN;

EID: 33745139817     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.04.006     Document Type: Article

References (52)

1. Guevara M., Gines P., Jimenez W., Sort O., Fernandez-Esparrach G., Escorsell A., Bataller R., Bosch J., Arroyo V., Rivera F., and Rodes J. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. Gastroenterology 114 (1998) 336-343
2. Tahan V., Avsar E., Karaca C., Uslu E., Eren F., Aydin S., Uzun H., Hamzaoglu H.O., Besisik F., Kalayci C., Okten A., and Tozun N. Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension. World J Gastroenterol 9 (2003) 2323-2327
3. Groszmann R.J. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 20 (1994) 1359-1363
4. Fernandez-Rodriguez C.M., Prada I.R., Prieto J., Montuenga L.M., Elssasser T., Quiroga J., Moreiras M., Andrade A., and Cuttitta F. Circulating adrenomedullin in cirrhosis: relationship to hyperdynamic circulation. J Hepatol 29 (1998) 250-256
5. Kojima H., Tsujimoto T., Uemura M., Takaya A., Okamoto S., Ueda S., Nishio K., Miyamoto S., Kubo A., Minamino N., Kangawa K., Matsuo H., and Fukui H. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis. J Hepatol 28 (1998) 840-846
6. Bendtsen F., Schifter S., and Henriksen J.H. Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis. J Hepatol 12 (1991) 118-123
7. Fernandez-Rodriguez C.M., Prieto J., Quiroga J., Zozoya J.M., Andrade A., Nunez M., Sangro B., and Penas J. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion. Hepatology 21 (1995) 35-40
8. Cheung B., and Leung R. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci (Lond) 92 (1997) 59-62
9. Hirano S., Imamura T., Matsuo T., Ishiyama Y., Kato J., Kitamura K., Koiwaya Y., and Eto T. Differential responses of circulating and tissue adrenomedullin and gene expression to volume overload. J Card Fail 6 (2000) 120-129
10. Braet F., and Wisse E. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol 1 1 (2002) 1
11. Niu P., Shindo T., Iwata H., Iimuro S., Takeda N., Zhang Y., Ebihara A., Suematsu Y., Kanagawa K., Hirata, and Nagai R. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage. Circulation 109 (2004) 1789-1794
12. Swaney J.S., Roth D.M., Olson E.R., Naugle J.E., Meszaros J.G., and Insel P.A. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc Natl Acad Sci 102 (2005) 437-442
13. Poyner D.R., Sexton P.M., Marshall I., Smith D.M., Quirion R., Born W., Muff R., Fischer J.A., and Foord S.M. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54 (2002) 233-246
14. Morfis M., Christopoulos A., and Sexton P.M. RAMPs: 5 years on, where to now?. Trends Pharmacol Sci 24 (2003) 596-601
15. Lopez-Parra M., Claria J., Planaguma A., Titos E., Masferrer J.L., Woerner B.M., Koki A.T., Jimenez W., Altuna R., Arroyo V., Rivera F., and Rodes J. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites. Br J Pharmacol 135 (2002) 891-900
16. Luk J.M., Wang P.P., Lee C.K., Wang J.H., and Fan S.T. Hepatic potentials of bone marrow stromal cells: development of in vitro co-culture and intraportal transplantation models. J Immunol Methods 305 (2005) 39-47
17. Cheung B.M.Y., Hwang I.S.S., Li C.Y.Y., O W.S., Tsang K.W.T., Leung R.Y.H., Kumana C.R., and Tang F. Increased adrenomedullin expression in lungs in endotoxaemia. J Endocrinol 181 (2004) 339-345
18. Hwang I.S., Cheung B.M., and Tang F. Increase in adrenomedullin gene expression in the left atrium and ventricle in the two-kidney one-clip renovascular hypertensive rats. Neuropeptides 37 (2003) 239-244
19. Hwang I.S.S., and Tang F. The distribution and gene expression of adrenomedullin in the rat brain: peptide/mRNA and precursor/active peptide relationships. Neurosci Lett 267 (1999) 85-88
20. Hwang I.S.S., and Tang F. Peripheral distribution and gene expression of adrenomedullin in the rat: possible source of blood adrenomedullin. Neuropeptides 34 (2000) 32-37
21. Luk J.M., Mok B.W., Shum C.K., Yeung W.S., Tam P.C., Tse J.Y., Chow J.F., Woo J., Kam K., and Lee K.F. Identification of novel genes expressed during spermatogenesis in stage-synchronized rat tests by differential display. Biochem Biophys Res Commun 307 (2003) 782-790
22. Hwang S.S.I., Autelitano D.J., Wong P.Y.D., Leung G.P.H., and Tang F. Co-expression of adrenomedullin and adrenomedullin receptors in rat epididymis: distinct physiological actions on anion transport. Biol Reprod 68 (2003) 2005-2012
23. Wong L.Y., Cheung B.M., Li Y.Y., and Tang F. Adrenomedullin is both proinflammatory and antiinflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line. Endocrinology 146 (2005) 1321-1327
24. Tsui T.Y., Lau C.K., Ma J., Wu X., Wang Y.Q., Farkas S., Xu R., Schlitt H.J., and Fan S.T. rAAV-mediated stable expression of heme oxygenase-1 in stellate cells: a new approach to attenuate liver fibrosis in rats. Hepatology 42 (2005) 335-342
25. Perez M.J., Sanchez-Medina F., Torres M., Gil A., and Suarez A. Dietary nucleotides enhance the liver redox state and protein synthesis in cirrhotic rats. J Nutr 134 (2004) 2504-2508
26. Cejudo-Martin P., Morales-Ruiz M., Ros J., Navasa M., Fernandez-Varo G., Fuster J., Rivera F., Arroyo V., Rodes J., and Jimenez W. Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients. Hepatology 36 (2002) 1172-1179
27. Moreau R., Lee S.S., Soupison T., Roche-Sicot J., and Sicot C. Abnormal tissue oxygenation in patients with cirrhosis and liver failure. J Hepatol 7 (1998) 98-105
28. Vachiery F., Moreau R., Hadengue A., Gadano A., Soupison T., Valla D., and Lebrec D. Hypoxemia in patients with cirrhosis: relationship with liver failure and hemodynamic alterations. J Hepatol 27 (1997) 492-495
29. Cormier-Regard S., Nguyen S.V., and Claycomb W.C. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 273 (1998) 17787-17792
30. Garayoa M., Martinez A., Lee S., Pio R., An W.G., Neckers L., Trepel J., Montuenga L.M., Ryan H., Johnson R., Gassmann M., and Cuttitta F. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol 14 (2000) 848-862
31. Kaneda K., Ekataksin W., Sogawa M., Matsumura A., Cho A., and Kawada N. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction. Hepatology 27 (1998) 735-747
32. Gorbig M.N., Gines P., Bataller R., Nicolas J.M., Garcia-Ramallo E., Cejudo P., Sancho-Bru P., Jimenez W., Arroyo V., and Rodes J. Human hepatic stellate cells secrete adrenomedullin: potential autocrine factor in the regulation of cell contractility. J Hepatol 34 (2001) 222-229
33. Hofbauer K.H., Jensen B.L., Kurtz A., and Sandner P. Tissue hypoxygenation activates the adrenomedullin system in vivo. Am J Physiol 278 (2000) R513-R519
34. Li Y.Y., Cheung B.M., Wong L.Y., Hwang I.S., Kumana C.R., and Tang F. Adrenomedullin gene expression and levels in the cardiovascular system after treatment with lipopolysaccharide. Neuropeptides 39 (2005) 73-80
35. Frances R., Rodriguez E., Munoz C., Zapater P., De la M.L., Ndongo M., Perez-Mateo M., and Such J. Intracellular cytokine expression in peritoneal monocyte/macrophages obtained from patients with cirrhosis and presence of bacterial DNA. Eur J Gastroenterol Hepatol 17 (2005) 45-51
36. Ando K., Shimosawa T., and Fujita T. Adrenomedullin in vascular diseases. Curr Hypertens Rep 6 1 (2004) 55-59
37. Krahenbuhl L., Lang C., Ludes S., Seiler C., Schafer M., Zimmermann A., and Krahenbuhl S. Reduced hepatic glycogen stores in patients with liver cirrhosis. Liver Int 23 2 (2003) 101-109
38. Dobrzynski E., Montanari D., Agata J., Zhu J., Chao J., and Chao L. Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 283 (2002) E1291-E1298
39. Ishiyama Y., Kitamura K., Ichiki Y., Nakamura S., Kida O., Kangawa K., and Eto T. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol 241 (1993) 271-273
40. Nuki C., Kawasaki H., Kitamura K., Takenaga M., Kangawa K., Eto T., and Wada A. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 196 (1993) 245-251
41. Jougasaki M., Wei C.M., Aarhus L.L., Heublein D.M., Sandberg S.M., and Burnett Jr. J. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol 268 (1995) F657-F663
42. Eto T., Kitamura K., and Kato J. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol 26 (1999) 371-380
43. Jensen B.L., Kramer B.K., and Kurtz A. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells. Hypertension 29 (1997) 1148-1155
44. Genesca J., Gonzalez A., Catalan R., Segura R., Martinez M., Esteban R., Groszmann R.J., and Guardia J. Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis: relationship to nitric oxide. Dig Dis Sci 44 (1999) 372-376
45. Kojima H., Sakurai S., Uemura M., Satoh H., Nakashima T., Minamino N., Kangawa K., Matsuo H., and Fukui H. Adrenomedullin contributes to vascular hyporeactivity in cirrhotic rats with ascites via a release of nitric oxide. Scand J Gastroenterol 7 (2004) 686-693
46. Fernandez-Rodriguez C.M., Prada I.R., Prieto J., Montuenga L.M., Elssasser T., Quiroga J., Moreiras M., Andrade A., and Cuttitta F. Circulating adrenomedullin in cirrhosis: relationship to hyperdynamic circulation. J Hepatol 29 (1998) 250-256
47. Sieber C.C., and Groszmann R.J. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 103 (1992) 235-239
48. Weigert A.L., Martin P.Y., Niederberger M., Higa E.M., McMurtry I.F., Gines P., and Schrier R.W. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 22 (1995) 1856-1862
49. Martin P.Y., Gines P., and Schrier R.W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 339 8 (1998) 533-541
50. Vallance P., and Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide?. Lancet 337 8744 (1991) 776-778
51. Shimekake Y., Nagata K., Ohta S., Kambayashi Y., Teraoka H., Kitamura K., Eto T., Kangawa K., and Matsuo H. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 270 (1995) 4412-4417
52. Cuttitta F., Pío R., Garayoa M., Zudaire E., Julián M., Elsasser T., Montuenga L.M., and Martíne Z.A. Adrenomedullin functions as an important tumor survival factor in human carcinogenesis. Microsc Res Tech 57 2 (2002) 110-119